Search Drugs Search BNF Categories Notes Click to View ALL BNF

>> >>
(Click to View Drug List)

Formulary Notes (BNF Chapter)

NICE Guidance (3)

Other Links (0)

Important Local Documents (5)

Notes for: Endocrine system
Last edited [18/11/2024 10:56:02]

Sharps Bins disposal

Cornwall Council: sharps bins collections information or 0300 1234 141

Isles of Scilly Council: For advice and disposal arrangements please contact St Mary's Hospital on 01720 422392

Last edited [18/11/2024 10:56:48]

Cornwall Joint Formulary Recommended Choices (...Top)

Displaying 13 Drugs

Key:

First Line Drugs

Second Line Drugs

Specialist advised

Specialist Initiated Drugs

Hospital Only Drugs

Discouraged

No comment available

	Name	Tariff	BNF Sub Paragraph
	Desmopressin tablet 200 mcg tab Pack of 30	£19.70	Posterior Pituitary Hormones&Antagonists
	Desmopressin Nasal Spray (Desmospray) 10 mcg / spray (60 sprays / 6ml pack) Pack of 1	£25.02	Posterior Pituitary Hormones&Antagonists
	Desmopressin Acetate (Desmotabs) 200 mcg tab Pack of 30	£29.43	Posterior Pituitary Hormones&Antagonists
	Desmopressin Nasal Spray 10 mcg / spray (60 sprays / 6ml pack) Pack of 1	£35.76	Posterior Pituitary Hormones&Antagonists
	Desmopressin Acetate (DDAVP) 200 mcg tab Pack of 90	£88.23	Posterior Pituitary Hormones&Antagonists
	Tolvaptan (Jinarc) 15 mg tablets Pack of 7	-	Posterior Pituitary Hormones&Antagonists
	Tolvaptan (Jinarc) 30 mg tablets Pack of 7	-	Posterior Pituitary Hormones&Antagonists
	Desmopressin (Octim) 150 mcg / ml nasal spray Pack of 2	-	Posterior Pituitary Hormones&Antagonists
	Tolvaptan (Samsca) 15 mg tab Pack of 10	-	Posterior Pituitary Hormones&Antagonists
NICE TA358 Tolvaptan is recommended as an option for the treatment of autosomal dominant polycystic kidney disease in adults when specified criteria are met (October 2015) Hyponatraemia secondary to SIADH in patients requiring cancer chemotherapy. Commissioned by NHS England
	Tolvaptan (Samsca) 30 mg tab Pack of 10	-	Posterior Pituitary Hormones&Antagonists
NICE TA358 Tolvaptan is recommended as an option for the treatment of autosomal dominant polycystic kidney disease in adults when specified criteria are met (October 2015) Hyponatraemia secondary to SIADH in patients requiring cancer chemotherapy. Commissioned by NHS England
	Tolvaptan (Jinarc) 45 mg tablets and Jinarc 15mg tablets Pack of 56	-	Posterior Pituitary Hormones&Antagonists
	Tolvaptan (Jinarc) 60 mg tablets and Jinarc 30mg tablets Pack of 56	-	Posterior Pituitary Hormones&Antagonists
	Tolvaptan (Jinarc) 90 mg tablets and Jinarc 30mg tablets Pack of 56	-	Posterior Pituitary Hormones&Antagonists